Zmetakova, I., Kalinkova, L., Smolkova, B., Horvathova Kajabova, V., Cierna, Z., Danihel, L., . . . Fridrichova, I. (2019). A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease‐free survival in low‐risk breast cancer patients. Cancer Sci.
Chicago Style CitationZmetakova, Iveta, et al. "A Disintegrin and Metalloprotease 23 Hypermethylation Predicts Decreased Disease‐free Survival in Low‐risk Breast Cancer Patients." Cancer Sci 2019.
Cita MLAZmetakova, Iveta, et al. "A Disintegrin and Metalloprotease 23 Hypermethylation Predicts Decreased Disease‐free Survival in Low‐risk Breast Cancer Patients." Cancer Sci 2019.
Atenció: Aquestes cites poden no estar 100% correctes.